Utility of serum DNA as a marker for KRAS mutations in pancreatic cancer tissue-Reference-Cited by-同舟云学术

Utility of serum DNA as a marker for KRAS mutations in pancreatic cancer tissue

Published:2017-03 Issue:2 Volume:17 Page:285-290
ISSN:1424-3903
Container-title:Pancreatology
language:en
Short-container-title:Pancreatology

Author:

Ako Soichiro,Nouso Kazuhiro,Kinugasa Hideaki,Dohi Chihiro,Matushita Hiroshi,Mizukawa Sho,Muro Shinichiro,Akimoto Yutaka,Uchida Daisuke,Tomoda Takeshi,Matsumoto Kazuyuki,Horiguchi Shigeru,Tsutsumi Koichiro,Kato Hironari,Okada Hiroyuki

Publisher

Elsevier BV

Subject

Gastroenterology,Hepatology,Endocrinology, Diabetes and Metabolism

Reference19 articles.

1. Global cancer statistics;Jemal;CA a cancer J Clin,2011

2. Progression model for pancreatic cancer. Clinical cancer research;Hruban;official J Am Assoc Cancer Res,2000

3. Presence of somatic mutations in most early-stage pancreatic intraepithelial neoplasia;Kanda;Gastroenterology,2012

4. Spinal cord compression due to carcinoid metastasis;Gray;Postgrad Med J,1988

5. Most human carcinomas of the exocrine pancreas contain mutant c-k-ras genes;Almoguera;Cell,1988

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Role of neoadjuvant therapy for nonmetastatic pancreatic cancer: Current evidence and future perspectives;World Journal of Gastrointestinal Oncology;2023-06-15

2. Peritoneal Cell-Free Tumor DNA is a Biomarker of Locoregional and Peritoneal Recurrence in Resected Pancreatic Ductal Adenocarcinomas;Annals of Surgical Oncology;2023-06-11

3. Circulating Tumor DNA Is an Accurate Diagnostic Tool and Strong Prognostic Marker in Pancreatic Cancer;Pancreas;2023-03

4. Clinical significance of circulating-tumour DNA analysis by metastatic sites in pancreatic cancer;British Journal of Cancer;2023-02-13

5. Liquid biopsy leads to a paradigm shift in the treatment of pancreatic cancer;World Journal of Gastroenterology;2022-12-14